AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion
Authors: Miller, KD Spooner, K Herpin, BR Rock-Kress, D Metcalf, JA Davey, RT Falloon, J Kovacs, JA Polis, RA Walker, RE Masur, H Lane, HC
Citation: Kd. Miller et al., Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion, CLIN IMMUNO, 99(1), 2001, pp. 30-42
Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients
Authors: Valdez, H Metcalf, JA Gripshover, BM Jacobson, JM Mitsuyasu, R Lederman, MM
Citation: H. Valdez et al., Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients, AIDS, 15(5), 2001, pp. 661-662
CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients
Authors: Sereti, I Herpin, B Metcalf, JA Stevens, R Baseler, MW Hallahan, CW Kovacs, JA Davey, RT Lane, HC
Citation: I. Sereti et al., CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients, AIDS, 15(14), 2001, pp. 1765-1775
Modelling mammary metabolism in the dairy cow to predict milk constituent yield, with emphasis on amino acid metabolism and milk protein production: Model construction
Authors: Hanigan, MD Crompton, LA Metcalf, JA France, J
Citation: Md. Hanigan et al., Modelling mammary metabolism in the dairy cow to predict milk constituent yield, with emphasis on amino acid metabolism and milk protein production: Model construction, J THEOR BIO, 213(2), 2001, pp. 223-239
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viralquasi species present before initiation of therapy
Authors: Imamichi, H Crandall, KA Natarajan, V Jiang, MK Dewar, RL Berg, S Gaddam, A Bosche, M Metcalf, JA Davey, RT Lane, HC
Citation: H. Imamichi et al., Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viralquasi species present before initiation of therapy, J INFEC DIS, 183(1), 2001, pp. 36-50
Evidence for increased T cell turnover and decreased thymic output in HIV infection
Authors: Douek, DC Betts, MR Hill, BJ Little, SJ Lempicki, R Metcalf, JA Casazza, J Yoder, C Adelsberger, JW Stevens, RA Baseler, MW Keiser, P Richman, DD Davey, RT Koup, RA
Citation: Dc. Douek et al., Evidence for increased T cell turnover and decreased thymic output in HIV infection, J IMMUNOL, 167(11), 2001, pp. 6663-6668
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
Authors: Kovacs, JA Vogel, S Metcalf, JA Baseler, M Stevens, R Adelsberger, J Lempicki, R Hengel, RL Sereti, I Lambert, L Dewar, RL Davey, RT Walker, RE Falloon, J Polis, MA Masur, H Lane, HC
Citation: Ja. Kovacs et al., Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy, EUR J IMMUN, 31(5), 2001, pp. 1351-1360
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression
Authors: Orenstein, JM Bhat, N Yoder, C Fox, C Polis, MA Metcalf, JA Kovacs, JA Falloon, J Walker, RE Masur, H Lane, HC Davey, RT
Citation: Jm. Orenstein et al., Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression, AIDS, 14(12), 2000, pp. 1709-1715
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
Authors: Hatano, H Vogel, S Yoder, C Metcalf, JA Dewar, R Davey, RT Polis, MA
Citation: H. Hatano et al., Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression, AIDS, 14(10), 2000, pp. 1357-1363
Prospects for minimizing phosphorus excretion in ruminants by dietary manipulation
Authors: Valk, H Metcalf, JA Withers, PJA
Citation: H. Valk et al., Prospects for minimizing phosphorus excretion in ruminants by dietary manipulation, J ENVIR Q, 29(1), 2000, pp. 28-36
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4(+) and CD8(+) T cell turnover in HIV-infected patients
Authors: Lempicki, RA Kovacs, JA Baseler, MW Adelsberger, JW Dewar, RL Natarajan, V Bosche, MC Metcalf, JA Stevens, RA Lambert, LA Alvord, WG Polis, MA Davey, RT Dimitrov, DS Lane, HC
Citation: Ra. Lempicki et al., Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4(+) and CD8(+) T cell turnover in HIV-infected patients, P NAS US, 97(25), 2000, pp. 13778-13783
Relative replication fitness of a high-level 3 '-azido-3 '-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69
Authors: Imamichi, T Berg, SC Imamichi, H Lopez, JC Metcalf, JA Falloon, J Lane, HC
Citation: T. Imamichi et al., Relative replication fitness of a high-level 3 '-azido-3 '-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69, J VIROLOGY, 74(23), 2000, pp. 10958-10964
High-level resistance to 3 '-azido-3 '-deoxythimidine due to a deletion inthe reverse transcriptase gene of human immunodeficiency virus type 1
Authors: Imamichi, T Sinha, T Imamichi, H Zhang, YM Metcalf, JA Falloon, J Lane, HC
Citation: T. Imamichi et al., High-level resistance to 3 '-azido-3 '-deoxythimidine due to a deletion inthe reverse transcriptase gene of human immunodeficiency virus type 1, J VIROLOGY, 74(2), 2000, pp. 1023-1028
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
Authors: Kovacs, JA Imamichi, H Vogel, S Metcalf, JA Dewar, RL Baseler, M Stevens, R Adelsberger, J Lambert, L Davey, RT Walker, RE Falloon, J Polis, MA Masur, H Lane, HC
Citation: Ja. Kovacs et al., Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression, J INFEC DIS, 182(4), 2000, pp. 1063-1069
CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4(+) T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: Potential contribution of anergy to HIV-specific unresponsiveness
Authors: Dybul, M Mercier, G Belson, M Hallahan, CW Liu, SY Perry, C Herpin, B Ehler, L Davey, RT Metcalf, JA Mican, JM Seder, RA Fauci, AS
Citation: M. Dybul et al., CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4(+) T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: Potential contribution of anergy to HIV-specific unresponsiveness, J IMMUNOL, 165(3), 2000, pp. 1685-1691
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus
Authors: Foster, CB Lehmbecher, T Samuels, S Stein, S Mol, F Metcalf, JA Wyvill, K Steinberg, SM Kovacs, J Blauvelt, A Yarchoan, R Chanock, SJ
Citation: Cb. Foster et al., An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus, BLOOD, 96(7), 2000, pp. 2562-2567
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection
Authors: Walker, RE Bechtel, CM Natarajan, V Baseler, M Hege, KM Metcalf, JA Stevens, R Hazen, A Blaese, RM Chen, CC Leitman, SF Palensky, J Wittes, J Davey, RT Falloon, J Polis, MA Kovacs, JA Broad, DF Levine, BL Roberts, MR Masur, H Lane, HC
Citation: Re. Walker et al., Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection, BLOOD, 96(2), 2000, pp. 467-474
Variant genotypes of Fc gamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men
Authors: Lehrnbecher, T Foster, CB Zhu, SX Venzon, D Steinberg, SM Wyvill, K Metcalf, JA Cohen, SS Kovacs, J Yarchoan, R Blauvelt, A Chanock, SJ
Citation: T. Lehrnbecher et al., Variant genotypes of Fc gamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men, BLOOD, 95(7), 2000, pp. 2386-2390
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
Authors: Whitcup, SM Fortin, E Lindblad, AS Griffiths, P Metcalf, JA Robinson, MR Manischewitz, J Baird, B Perry, C Kidd, IM Vrabec, T Davey, RT Falloon, J Walker, RE Kovacs, JA Lane, HC Nussenblatt, RB Smith, J Masur, H Polis, MA
Citation: Sm. Whitcup et al., Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis, ARCH OPHTH, 118(5), 2000, pp. 704-704
Effect of interleukin-2 on the pool of latently infected, resting CD4(+) Tcells in HIV-1-infected patients receiving highly active anti-retroviral therapy
Authors: Chun, TW Engel, D Mizell, SB Hallahan, CW Fischette, M Park, S Davey, RT Dybul, M Kovacs, JA Metcalf, JA Mican, JM Berrey, MM Corey, L Lane, HC Fauci, AS
Citation: Tw. Chun et al., Effect of interleukin-2 on the pool of latently infected, resting CD4(+) Tcells in HIV-1-infected patients receiving highly active anti-retroviral therapy, NAT MED, 5(6), 1999, pp. 651-655
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
Authors: Orenstein, JM Feinberg, M Yoder, C Schrager, L Mican, JM Schwartzentruber, DJ Davey, RT Walker, RE Falloon, J Kovacs, JA Miller, KD Fox, C Metcalf, JA Masur, H Polis, MA
Citation: Jm. Orenstein et al., Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient, AIDS, 13(16), 1999, pp. 2219-2229
HIV-1 replication in patients with undetectable plasma virus receiving HEART
Authors: Natarajan, V Bosche, M Metcalf, JA Ward, DJ Lane, HC Kovacs, JA
Citation: V. Natarajan et al., HIV-1 replication in patients with undetectable plasma virus receiving HEART, LANCET, 353(9147), 1999, pp. 119-120
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
Authors: Whitcup, SM Fortin, E Lindblad, AS Griffiths, P Metcalf, JA Robinson, MR Manischewitz, J Baird, B Perry, C Kidd, IM Vrabec, T Davey, RT Falloon, J Walker, RE Kovacs, JA Lane, HC Nussenblatt, RB Smith, J Masur, H Polis, MA
Citation: Sm. Whitcup et al., Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis, J AM MED A, 282(17), 1999, pp. 1633-1637
Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
Authors: Highbarger, HC Alvord, WG Jiang, MK Shah, AS Metcalf, JA Lane, HC Dewar, RL
Citation: Hc. Highbarger et al., Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples, J CLIN MICR, 37(11), 1999, pp. 3612-3614
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Authors: Davey, RT Bhat, N Yoder, C Chun, TW Metcalf, JA Dewar, R Natarajan, V Lempicki, RA Adelsberger, JW Millers, KD Kovacs, JA Polis, MA Walker, RE Falloon, L Masur, H Gee, D Baseler, M Dimitrov, DS Fauci, AS Lane, HC
Citation: Rt. Davey et al., HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression, P NAS US, 96(26), 1999, pp. 15109-15114
Risultati: 1-25 | 26-28